Hepatología: porfirias y carcinogénesis
University of Bordeaux
Burdeos, FranciaPublications in collaboration with researchers from University of Bordeaux (9)
2001
-
Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria
Molecular Therapy, Vol. 3, Núm. 3, pp. 411-417
-
Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection
Molecular Therapy, Vol. 4, Núm. 4, pp. 331-338
-
Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection
Journal of Viral Hepatitis, Vol. 8, Núm. 1, pp. 41-47
-
Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells
Gene Therapy, Vol. 8, Núm. 8, pp. 618-626
2000
-
Reversion of hepatobiliary alterations by bone marrow transplantation in a murine model of erythropoietic protoporphyria
Hepatology, Vol. 32, Núm. 1, pp. 73-81
1999
-
A novel immunodeficient mouse model - RAG2 x common cytokine receptor γ chain double mutants - Requiring exogenous cytokine administration for human hematopoietic stem cell engraftment
Journal of Interferon and Cytokine Research, Vol. 19, Núm. 5, pp. 533-541
-
Fluorescence-based Selection of Retrovirally Transduced Cells in Congenital Erythropoietic Porphyria: Direct Selection Based on the Expression of the Therapeutic Gene
Journal of Gene Medicine, Vol. 1, Núm. 5, pp. 322-330
-
Perspectives de therapie genique en hematologie
Annales de Biologie Clinique, Vol. 57, Núm. 1, pp. 43-50
1998
-
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection
Hepatology, Vol. 27, Núm. 2, pp. 584-589